Benbrook DM - Search Results

1

Niclosamide causes lysosome-dependent cell death in endometrial cancer cells and tumors.

Rai R, Dey DK, Benbrook DM, Chandra V. Rai R, et al. Among authors: benbrook dm. Biomed Pharmacother. 2023 May;161:114422. doi: 10.1016/j.biopha.2023.114422. Epub 2023 Feb 23. Biomed Pharmacother. 2023. PMID: 36841028 Free article.

2

Association of Sialyl Tn antigen with cervical cancer lymph node status: An NRG oncology/GOG study.

Benbrook DM, Deng W, Gold MA, Rai R, Conrad R, van der Wel H, Husain S, Moore K, Spirtos N, Jackson AL, Zakhour M, Mathews CA, West CM. Benbrook DM, et al. Gynecol Oncol. 2023 Apr;171:67-75. doi: 10.1016/j.ygyno.2023.02.001. Epub 2023 Feb 22. Gynecol Oncol. 2023. PMID: 36827840 Free PMC article.

3

Dataset on mucin 1 and 4 proteins and SialyT and T antigens staining patterns in cervical cancer primary tumors and metastatic lymph nodes.

Rai R, Conrad R, Benbrook DM. Rai R, et al. Among authors: benbrook dm. Data Brief. 2023 May 18;48:109243. doi: 10.1016/j.dib.2023.109243. eCollection 2023 Jun. Data Brief. 2023. PMID: 37383750 Free PMC article.

4

Pharmacodynamics of Cyclin D1 Degradation in Ovarian Cancer Xenografts with Repeated Oral SHetA2 Dosing.

Sharma A, Liu X, Chandra V, Rai R, Benbrook DM, Woo S. Sharma A, et al. Among authors: benbrook dm. AAPS J. 2023 Dec 12;26(1):5. doi: 10.1208/s12248-023-00874-7. AAPS J. 2023. PMID: 38087107

5

Association between Serum Biomarkers with Postoperative Complications and Delay of Adjuvant Chemotherapy Initiation in Ovarian Cancer Patients Undergoing Primary Cytoreductive Surgery: A Pilot Study.

Ade CJ, Dockery L, Walter AC, Benbrook DM, Vesely SK, Hammond ST, Moore KN, Holman LL. Ade CJ, et al. Among authors: benbrook dm. Nutr Cancer. 2023;75(2):662-669. doi: 10.1080/01635581.2022.2152060. Epub 2022 Dec 10. Nutr Cancer. 2023. PMID: 36495155 Free PMC article.

6

Manipulation of metabolic responses enhances SHetA2 efficacy without toxicity in cervical cancer cell lines and xenografts.

Rai R, Lightfoot S, Benbrook DM. Rai R, et al. Among authors: benbrook dm. Gynecol Oncol. 2024 Jan;180:44-54. doi: 10.1016/j.ygyno.2023.11.013. Epub 2023 Dec 5. Gynecol Oncol. 2024. PMID: 38052108

7

Distinct mechanism of cervical cancer cell death caused by the investigational new drug SHetA2.

Rai R, Chandra V, Kennedy AL, Zuna RE, Benbrook DM. Rai R, et al. Among authors: benbrook dm. Front Oncol. 2022 Sep 20;12:958536. doi: 10.3389/fonc.2022.958536. eCollection 2022. Front Oncol. 2022. PMID: 36203464 Free PMC article.

8

Identification of Candidate Biomarker and Drug Targets for Improving Endometrial Cancer Racial Disparities.

Javadian P, Xu C, Sjoelund V, Borden LE, Garland J, Benbrook DM. Javadian P, et al. Among authors: benbrook dm. Int J Mol Sci. 2022 Jul 14;23(14):7779. doi: 10.3390/ijms23147779. Int J Mol Sci. 2022. PMID: 35887124 Free PMC article.

9

Sera Protein Signatures of Endometrial Cancer Lymph Node Metastases.

Benbrook DM, Hocker JRS, Moxley KM, Hanas JS. Benbrook DM, et al. Int J Mol Sci. 2022 Mar 18;23(6):3277. doi: 10.3390/ijms23063277. Int J Mol Sci. 2022. PMID: 35328698 Free PMC article.

10

SHetA2 Attack on Mortalin and Colleagues in Cancer Therapy and Prevention.

Benbrook DM. Benbrook DM. Front Cell Dev Biol. 2022 Feb 23;10:848682. doi: 10.3389/fcell.2022.848682. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35281109 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

108 results

Search Page